found that IL-21 can augment the aggregation and amplification capacity of poorly differentiated CAR-T cells and effectively increase the cytotoxicity of HER2-targeted CAR-T cells to HER2-overexpressing cells by increasing cytokine secretion in breast cancer. Here, ERBB2 is linked to breast cancer.